Office of the Director, National Institutes of Health; Notice of Meeting, 5592 [2011-2190]
Download as PDF
<![CDATA[
5592
Federal Register / Vol. 76, No. 21 / Tuesday, February 1, 2011 / Notices
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Michael W. Edwards, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 750, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8886,
edwardsm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: January 26, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–2191 Filed 1–31–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
srobinson on DSKHWCL6B1PROD with NOTICES
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Scientific Management Review Board.
The NIH Reform Act of 2006 (Pub. L.
109–482) provides organizational
authorities to HHS and NIH officials to:
(1) Establish or abolish national research
institutes; (2) reorganize the offices
within the Office of the Director, NIH
including adding, removing, or
transferring the functions of such offices
or establishing or terminating such
offices; and (3) reorganize, divisions,
centers, or other administrative units
within an NIH national research
institute or national center including
adding, removing, or transferring the
functions of such units, or establishing
or terminating such units. The purpose
of the Scientific Management Review
Board (also referred to as SMRB or
Board) is to advise appropriate HHS and
NIH officials on the use of these
organizational authorities and identify
the reasons underlying the
recommendations.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
VerDate Mar<15>2010
15:05 Jan 31, 2011
Jkt 223001
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Scientific
Management Review Board.
Date: February 23, 2011.
Time: 11:30 a.m. to 1:30 p.m.
Agenda: Presentation and discussion will
focus on NIH activities related to the Board’s
recommendations to create a new center for
advancing translational medicine and
therapeutics development. As requested by
the Board in its Report on Translational
Medicine and Therapeutics, NIH will provide
an update on the proposed creation of a new
center and its evaluation of the impact of
such a center on other relevant extant
programs at NIH, including the National
Center for Research Resources. The Board
will also discuss next steps regarding future
SMRB activities. Time will be allotted on the
agenda for public comment. To sign up for
public comment, please submit your name
and affiliation to the contact person listed
below by February 22, 2011. Sign up will be
restricted to one sign up per e-mail. In the
event that time does not allow for all those
interested to present oral comments, anyone
may file written comments using the contact
person address below.
The toll-free number to participate in the
teleconference is 1–800–779–1545. Indicate
to the conference operator that your
Participant pass code is ‘‘NIH’.
Place: National Institutes of Health, Office
of the Director, NIH, Office of Science Policy,
6705 Rockledge Drive, Suite 750, Bethesda,
MD 20892, (Telephone Conference Call)
Contact Person: Lyric Jorgenson, Office of
Science Policy, Office of the Director, NIH,
National Institutes of Health, 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892,
smrb@mail.nih.gov, (301) 496–6837.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
The draft meeting agenda, meeting
materials, dial-in information, and other
information about the SMRB, will be
available at https://smrb.od.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: January 25, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–2190 Filed 1–31–11; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors for Basic
Sciences National Cancer Institute. The
meeting will be closed to the public as
indicated below in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Basic Sciences National
Cancer Institute.
Date: March 7, 2011.
Time: 9 to 4 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators
Place: National Institutes of Health,
National Cancer Institute, 9000 Rockville
Pike, Building 31, Conference Room 6,
Bethesda, MD 20892.
Contact Person: Florence E. Farber, PhD,
Executive Secretary, Office of the Director,
National Cancer Institute, National Institutes
of Health, 6116 Executive Boulevard, Room
2205, Bethesda, MD 20892, (301) 496–7628,
FF6P@mail.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/bsc/BS/BS.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
E:\FR\FM\01FEN1.SGM
01FEN1
]]>Agencies
[Federal Register Volume 76, Number 21 (Tuesday, February 1, 2011)]
[Notices]
[Page 5592]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-2190]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Scientific Management Review Board.
The NIH Reform Act of 2006 (Pub. L. 109-482) provides
organizational authorities to HHS and NIH officials to: (1) Establish
or abolish national research institutes; (2) reorganize the offices
within the Office of the Director, NIH including adding, removing, or
transferring the functions of such offices or establishing or
terminating such offices; and (3) reorganize, divisions, centers, or
other administrative units within an NIH national research institute or
national center including adding, removing, or transferring the
functions of such units, or establishing or terminating such units. The
purpose of the Scientific Management Review Board (also referred to as
SMRB or Board) is to advise appropriate HHS and NIH officials on the
use of these organizational authorities and identify the reasons
underlying the recommendations.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Scientific Management Review Board.
Date: February 23, 2011.
Time: 11:30 a.m. to 1:30 p.m.
Agenda: Presentation and discussion will focus on NIH activities
related to the Board's recommendations to create a new center for
advancing translational medicine and therapeutics development. As
requested by the Board in its Report on Translational Medicine and
Therapeutics, NIH will provide an update on the proposed creation of
a new center and its evaluation of the impact of such a center on
other relevant extant programs at NIH, including the National Center
for Research Resources. The Board will also discuss next steps
regarding future SMRB activities. Time will be allotted on the
agenda for public comment. To sign up for public comment, please
submit your name and affiliation to the contact person listed below
by February 22, 2011. Sign up will be restricted to one sign up per
e-mail. In the event that time does not allow for all those
interested to present oral comments, anyone may file written
comments using the contact person address below.
The toll-free number to participate in the teleconference is 1-
800-779-1545. Indicate to the conference operator that your
Participant pass code is ``NIH'.
Place: National Institutes of Health, Office of the Director,
NIH, Office of Science Policy, 6705 Rockledge Drive, Suite 750,
Bethesda, MD 20892, (Telephone Conference Call)
Contact Person: Lyric Jorgenson, Office of Science Policy,
Office of the Director, NIH, National Institutes of Health, 6705
Rockledge Drive, Suite 750, Bethesda, MD 20892, smrb@mail.nih.gov,
(301) 496-6837.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
The draft meeting agenda, meeting materials, dial-in
information, and other information about the SMRB, will be available
at https://smrb.od.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: January 25, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-2190 Filed 1-31-11; 8:45 am]
BILLING CODE 4140-01-P
